Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

被引：6
|
作者：
Lora-Tamayo, Jaime [1 ]
Maestro, Guillermo [1 ]
Lalueza, Antonio [1 ]
Rubio-Rivas, Manuel [2 ]
Villarreal Paul, Gracia [3 ]
Arnalich Fernandez, Francisco [4 ]
Beato Perez, Jose Luis [5 ]
Vargas Nunez, Juan Antonio [6 ]
Llorente Barrio, Monica [7 ]
Lumbreras Bermejo, Carlos [1 ]
机构：
[1] 12 Octubre Univ Hosp, Res Inst Hosp 12 Octubre I 12 Inst, Internal Med Dept, Madrid, Spain
[2] Bellvitge Univ Hosp IDIBELL, Internal Med Dept, Lhospitalet De Llobregat, Barcelona, Spain
[3] Gregorio Maranon Univ Hosp, Internal Med Dept, Madrid, Spain
[4] La Paz Univ Hosp, Internal Med Dept, Madrid, Spain
[5] Albacete Univ Hosp Complex, Internal Med Dept, Albacete, Spain
[6] Puerta Hierro Univ Hosp, Internal Med Dept, Majadahonda, Madrid, Spain
[7] Miguel Servet Hosp, Internal Med Dept, Zaragoza, Spain
来源：
JOURNAL OF INFECTION | 2021年 / 82卷 / 06期
关键词：
D O I：
10.1016/j.jinf.2021.02.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：293 / 298
页数：6
相关论文
共 50 条
  • [31] Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19
    Klement-Frutos, Elise
    Burrel, Sonia
    Peytavin, Gilles
    Marot, Stephane
    Le, Minh P.
    Godefroy, Nagisa
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Caumes, Eric
    Pourcher, Valerie
    Boutolleau, David
    JOURNAL OF INFECTION, 2021, 82 (01) : 194 - 197
  • [32] Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
    Zhu, Zhen
    Lu, Zhaohui
    Xu, Tianmin
    Chen, Cong
    Yang, Gang
    Zha, Tao
    Lu, Jianchun
    Xue, Yuan
    JOURNAL OF INFECTION, 2020, 81 (01) : E21 - E23
  • [33] Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
    Mazan, Paula
    Lesiak, Aleksandra
    Skibinska, Malgorzata
    Kamerys, Juliusz
    Czajkowski, Rafal
    Owczarek, Witold
    Narbutt, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (03): : 435 - 437
  • [34] Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study
    Elmekaty, Eman Zeyad, I
    Alibrahim, Rim
    Hassanin, Rania
    Eltaib, Sitelbanat
    Elsayed, Ahmed
    Rustom, Fatima
    Ibrahim, Mohamed Izham Mohamed
    Abu Khattab, Mohammed
    Al Soub, Hussam
    Al Maslamani, Muna
    Al-Khal, Abdullatif
    PLOS ONE, 2022, 17 (05):
  • [35] Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir
    Burgos-Blasco, Barbara
    Guemes-Villahoz, Noemi
    Vidal-Villegas, Beatriz
    Donate-Lopez, Juan
    Garcia-Feijoo, Julian
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 644 - 646
  • [36] Effects of Shallomin with Lopinavir/Ritonavir on clinical outcomes and mortality in COVID-19 patients: A randomised double-blind clinical trial study
    Amin, Mansour
    Nosratabadi, Mahnaz
    Mohseni, Seifollah
    Moazen, Javad
    Mehdipour, Shiva
    Rayhan, Hamed
    Masoudiyekta, Leila
    Akbari, Akbar
    Maghsodi, Fatemeh
    Barzegari, Ebrahim
    Jamalan, Mostafa
    JOURNAL OF HERBAL MEDICINE, 2023, 41
  • [37] The comparison of favipiravir and lopinavir/ritonavir combination in COVID-19 treatment
    Cinarka, Halit
    Gunluoglu, Gulsah
    Cortuk, Mustafa
    Yurt, Sibel
    Kiyik, Murat
    Kosar, Filiz
    Tanriverdi, Elif
    Arslan, Melih Akay
    Baydili, Kursad Nuri
    Koc, Aysu Sinem
    Altin, Sedat
    Cetinkaya, Erdogan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1624 - 1630
  • [38] Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients
    Zanon, D.
    Musazzi, U. M.
    Manca, A.
    Nicolo, A. De
    D'Avolio, A.
    Cilurzo, F.
    Maximova, N.
    Tomasello, C.
    Clementi, E.
    Minghetti, P.
    DATA IN BRIEF, 2020, 33
  • [39] Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
    Dario Cattaneo
    Mario Corbellino
    Cristina Gervasoni
    European Journal of Clinical Pharmacology, 2021, 77 : 791 - 792
  • [40] Consultation psychiatry in COVID-19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs
    Marcatili, Matteo
    Stefana, Alberto
    Colmegna, Fabrizia
    di Giacomo, Ester
    D'Amico, Emiliano
    Capuzzi, Enrico
    Dakanalis, Antonios
    Clerici, Massimo
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (04) : 145 - 146
12345